Statistics
Publications
2
Citations
66
H-Index
2
Active since
2020
Affiliations
Deniz Lengerli is an author at Hacettepe University specializing in molecular oncology, oncology, and cell-cycle dysregulation.
Publications per year
2020–2023
2
2
A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate
Özge Akbulut, Deniz Lengerli, Özge Saatci et al. · Molecular Cancer Therapeutics · 2020 · 31 citations · Full text
Medicine, Oncology, Pharmacology +14
1–2 of 2